Incorporating patients' characteristics in cost-effectiveness studies with clinical trial data: a flexible Bayesian approach

• Autores: Francisco José Vázquez Polo
• Localización: Sort: Statistics and Operations Research Transactions, ISSN 1696-2281, Vol. 28, Nº. 1, 2004, págs. 87-108
• Idioma: inglés
• Títulos paralelos:
  • Incorporación de las características de los pacientes a los estudios coste-eficacia con datos de ensayos clínicos: un enfoque bayesiano flexible.
• Enlaces
  • Texto completo (pdf)
• Dialnet Métricas: 1 Cita
• Resumen

  • Most published research on the comparison between medical treatment options merely compares the results (effectiveness and cost) obtained for each treatment group. The present work proposes the incorporation of other patient characteristics into the analysis. Most of the studies carried out in this context assume normality of both costs and effectiveness. In practice, however, the data are not always distributed according to this assumption. Alternative models have to be developed.

    In this paper, we present a general model of cost-effectiveness, incorporating both binary effectiveness and skewed cost. In a practical application, we compare two highly active antiretroviral treatments applied to asymptomatic HIV patients.

    We propose a logit model when the effectiveness is measured depending on whether an initial purpose is achieved. For this model, the measure to compare treatments is the difference in the probability of success. Besides, the cost data usually present a right skewing. We propose the use of the log-transformation to carry out the regression model. The three models are fitted demonstrating the advantages of this modelling. The cost-effectiveness acceptability curve is used as a measure for decision-making

• Referencias bibliográficas
  • Al, M.J. and Van Hout, B.A. (2000). A Bayesian approach to economic analysis of clinical trials: the case of Stenting versus Balloon Angioplasty,...
  • Albert, C.H. and Chib, S. (1993). Bayesian analysis of binary and polychotomus response data, Journal of the American Statistical Association,...
  • Berry, D.A. (1996). Statistics: a Bayesian Perspective. Belmont, CA: Duxbury Press.
  • Box, G.E.P. and Tiao, G.C. (1973). Bayesian Inference in Statistical Analysis. Reading, MA: AddisonWesley.
  • Briggs, A.H. (1999). A Bayesian approach to stochastic cost-effectiveness analysis, Health Economics, 8, 257-261.
  • Briggs, A.H. (2001). A Bayesian approach to stochastic cost-effectiveness analysis. An illustration and application to blood pressure control...
  • Brooks R., with the EuroQol Group. (1996). EuroQol the current state of play, Health Policy, 37, 53-72.
  • Carlin B.P. and Polson N.G. (1992). Monte Carlo Bayesian methods for discrete regression models and categorical time series, Bayesian Statistics,...
  • Chaloner, K. and Duncan, G.T. (1983). Assessment of a Beta prior distribution: PM Elicitation, Journal of the Royal Statistical Society, D...
  • Chaloner, K. (1995). The elicitation of prior distributions. In Berry, D. and Stangl, D. (eds). Case Studies in Bayesian Biostatistics. Marcel...
  • Chaloner, K. and Rhame, F.S. (2001). Quantifying and documenting prior beliefs in clinical trials, Statistics in Medicine, 20, 581-600.
  • Cox, D.R. (1971). The Analysis of Binary Data. London: Mehtuen.
  • Deeks, J. (1998). Odds ratios should be used only in case-control studies and logistic regression analysis, Bristish Medical Journal, 317,...
  • Freedman, L.S. and Spiegelhalter, D.J. (1983). The assessment of subjective opinion and its use in relation to stopping rules for clinical...
  • Gelman, A., Carlin, J., Stern, H.S. Rubin, D.B. et al. (1995). Bayesian Data Analysis. London: Chapman & Hall.
  • Geman, R., and Geman, D. (1984). Stochastic relaxation, Gibbs distributions and the Bayesian restoration of images, IEEE Trans. on Pattern...
  • Gilks, W.R., Richardson, S. and Spiegelhalter, D.J. (1996). Markov Chain Monte Carlo in Practice. London: Chapman & Hall.
  • Heitjan, D.F. (1997). Bayesian interim analysis of phase II cancer clinical trials, Statistics in Medicine, 16, 1791-1802.
  • Heitjan, D.F., Moskowitz, A.J. and William, W. (1999). Bayesian estimation of cost-effectiveness ratios from clinical trials, Health Economics,...
  • Hoch, J.S., Briggs, A.H. and Willan, A. (2002). Something olds, something new, something borrowed, something BLUE: a framework for the marriage...
  • Jones, D.A. (1996). A Bayesian approach to the economic evaluation of health care technologies. In Spiker (eds). Quality of Life and Pharmaeconomics...
  • Kadane, J.B. (1980). Predictive and structural methods for eliciting prior distributions. In Zellner, A. (eds.) Bayesian Analysis in Econometrics...
  • Kadane, J.B. and Wolfson, L.J. (1995). Priors for the design and analysis of clinical trials. In Berry, D. and Stangl, D. (eds.) Bayesian...
  • Kadane, J.B. and Wolfson, L.J. (1998). Experiences in elicitation, Journal of the Royal Statistical Society, D (The Statistician), 47, 3-19.
  • Laska, E.M., Meisner, M. and Siegel, C. (1997). Statistical inference for cost-effectiveness ratios, Health Economics, 6, 229-242.
  • Lothgren, M. and Zethraeus, N. (2000). Definition, interpretation and ca ¨ lculation of cost-effectiveness acceptability curves, Health Economics,...
  • Maddala, G.S. (1983). Limited Dependent and Qualitative Variables in Econometrics. New York: Cambridge University Press.
  • McFadden, D. (1974). Conditional logit analysis of qualitative choice behaviour. In Zarembka, P. (eds.) Frontiers of Econometrics. New York:...
  • Mullahy, J. and Stinnett, A. (1998). Net health benefits: a new framework for the analysis of uncertainty in cost effectiveness analysis,...
  • Nelder, J.A. and McCullagh, P. (1989). Generalized Linear Models. New York: Chapman & Hall.
  • O’Hagan, A. and Stevens, J.W. (2001a). Framework for cost-effectiveness analysis from clinical trial Data, Health Economics, 10, 303-315.
  • O’Hagan, A. and Stevens, J.W. (2001b). Bayesian assessment of sample size for clinical trials of costeffectiveness, Medical Decision Making,...
  • O’Hagan, A., Stevens, J.W., and Montmartin, J. (2001). Bayesian cost-effectiveness analysis from clinical trial data, Statistics in Medicine,...
  • O’Hagan, A. and Stevens, J.W. (2002). Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality?,...
  • Pinto, J.L., Lopez C., Bad ´ ´ıa, X., Coma, A. et al. (2000). Analisis coste-efectividad del tratamiento antirretroviral de gran actividad...
  • Spiegelhalter, D.J., Feedman, L.S. and Parmar, M.K.B. (1994). Bayesian approaches to randomized trials (with discussion), Journal of the Royal...
  • Spiegelhalter, D.J., Thomas, A. and Best, N. (1999). WinBUGS, version 1.2. MRC Biostatistics Unit: Cambridge, U.K.
  • Stinnett, A.A. and Mullahy, J. (1998). Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis,...
  • Tambour, M., Zethraeus, N. and Johannesson, M. (1998). A note on confidence intervals in cost-effectiveness analysis, International Journal...
  • Tweedie, R.L. (1998). Markov chains: structure and applications. Technical Report, Department of Statistics, Colorado State University.
  • Van Hout, B.A., Al, M.J., Gordon, G.S. and Rutten, F.F. (1994). Costs, effects and C/E-ratios alongside a clinical trial, Health Economics,...
  • Wakker, P. and Klaassen, M.P. (1995). Confidence intervals for cost-effectiveness ratios, Health Economics, 4, 373-381.
  • Willam, A.R. and O’Brien, B.J. (1996). Confidence intervals for cost-effectiveness ratios: an application of Fieller’s theorem, Health Economics,...
  • Willan, A.R., Briggs, A.H., Hoch, J.S. (2004). Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness...
  • Winkler, R.L. (1967). The assessment of prior distributions in Bayesian analysis, Journal of the American Statistical Association, 63, 776-800.
  • Wolpert, R.L. (1989). Eliciting and combining subjective judgements about uncertainty, International Journal of Technology Assessment in Health...